InsidersTradesSigma
Track the 큐리언트 stock price and the full management transaction log of the company, a listed equity based in South Korea. Shares are quoted on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 큐리언트 has published 103 insider filings. Market capitalisation: €814.2bn. The latest transaction was filed on 3 April 2026 (Purchase). Among the most active insiders: 동구바이오제약. Every trade is openly available.
101
Insider Decl.
n/a
Thresholds
€42,602
32 ops.
Buy Volume
n/a
5 ops.
Sell Volume
16Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 27,481 of 29,057 companies
16.4
score / 100
Value24
Quality9
FCF yld-4.2%
Earn yld-3.9%
EV/EBITDA·
ROE-75%
Gross mgn13%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 3 April 2026
Declarations103 total
Other
Other
80,000 sharesKRXDART:20260303002340
1,487,693 sharesKRXDART:20241129000711
1,661,065 sharesKRXDART:20241029000023
1,661,065 sharesKRXDART:20241028000395
5,037,281 sharesKRXDART:20240805000130
25 of 103 declarations
Acerca de 큐리언트
큐리언트 es una empresa del sector de la salud y farmacéutico, que cotiza en el mercado XKRX. Se centra en el desarrollo de tratamientos innovadores para diversas enfermedades.